Policy | March 14, 2022
Draft policy on medical devices released
Feedback and remarks of the industry and stakeholders are invited till the 25th of March 2022
Feedback and remarks of the industry and stakeholders are invited till the 25th of March 2022
Its technology-centric solutions enable hospitals to enhance operational efficiency and enable faster clinical decision making
In numerous neurological and rare disorders, where clinical characteristics can be confusing, NGS-based approaches have demonstrated considerable increases in disease detection rates over other approaches
A total of 49 projects have been approved so far for 33 critical APIs with a committed investment of Rs 3,685 crore
Dr. Bibikova is an international leader with over 25 years of experience in genomics industry
The accelerated growth of Medix Biochemica will establish its status as the ultimate IVD raw materials supplier
It is the first approved blood test that can predict likely progression to Alzheimer's Disease up to six years in advance
The acquisition of myPOLS Biotec complements Medix Biochemica’s leading portfolio of IVD raw materials and expands its reagent offerings for molecular diagnostics
It provides Covid-19 detection and Omicron surveillance in less than two hours
TATA MD’s OmiSure is the only test approved by the ICMR for RT-PCR detection of the Omicron variant
Subscribe To Our Newsletter & Stay Updated
